About

Prof. Dr. Berrin Pehlivan graduated from Hacettepe University Medical Faculty … With the motivation of cancer cases that Pehlivan encountered frequently in her family and surroundings, she turned onto Oncology and made observations in the Department of Radiation Oncology at Boston University where she spent her internship period. After completing her Radiation Oncology specialization training at Hacettepe University, she stayed abroad for a long time.

Improving herself constantly by researching global technologies in the cancer fight, Pehlivan took part in many scientific studies in France and Switzerland between 2004 and 2009. Continuing to her studies at the French European Cancerology Program, Lausanne University Radiation Oncology Department, Switzerland Villigen Paul Scherrer Institute Proton Therapy Center and France Orsay Proton Therapy Center, Pehlivan returned to Turkey to share her experiences with her own people at first hand.

After her studies at Başkent University and Akdeniz University Faculty of Medicine, she established Antalya Medstar Hospital Radiation Oncology Department under the Memorial Health Group.

Having put her signature under many national and international articles, scientific publications and projects, Pehlivan worked at Bahçelievler Medical Park Hospital, Göztepe Medical Park Hospital and Altınbaş University until the end of 2018. She also wrote a book called “Cancer in 50 Questions”. She continues to write articles for the Science Corner of “Cadde” Supplement of Milliyet Newspaper. Prof. Dr. Berrin Pehlivan currently trains the scientist of the future as a faculty member at Bahçeşehir University Radiation Oncology Department and continues to work in her own clinic.

Education

1993-2000Hacettepe University, Faculty of Medicine, Ankara/Turkey
1999Boston University Radiation Oncology Departement, Boston/USA
2001-2004Hacettepe University, Faculty of Medicine Radiation Oncology
Departement, Ankara/Turkey
2004-2005D.U.E.R.C.C. ‘Diplome Universitaire Europeen de Recherche Clinique en
Cancérologie’, Institut Gustave- Roussy, Paris/France
2005-2006‘Diploma Universitaire de Radiobiologie’, Institut Gustave-Roussy, Paris / France
2006-2007Fellowship, University Hospital of Lausanne, Radiation Oncology Departement, Lausanne/Switzerland
2007-2008‘Visiting Scientist’, Paul Scherrer Institute, Protontherapy Center, Villigen/Switzerland
2008-2009‘Visiting Scientist’ Orsay Protontherapy Center, Orsay/France
2009-2010Assistant. Prof., University of Baskent, Adana/Turkey
2010-2012Assistant. Prof., University of Akdeniz, Antalya/Turkey
2012-Associated Prof, Memorial Health Group, Medstar Antalya Hospital, Antalya/Turkey

Scientific Articles

A1.  Topkan E, Küçük A, Şenyürek S, Sezen D, Durankuş NK, Aydemir EY, İkiz ED, Bölükbaşı Y, Pehlivan B and Selek U. Preoperative radiosurgery in management of brain metastases. J Cancer Tumor Int, 2020.

A2. Topkan E, Küçük A, Sezen D, Senyürek S,  Aydemir EY, Durankuş N, İkiz ED, Bolükbaşı Y, Pehlivan B and Selek U. Clin Oncol Res, 2020.

A3. Pehlivan B, Sengul K, Yesil A, Nalbant N, Ozturk O, Ozdemir Y, Topkan E. Dosimetric comparison of lung-sparing radiation therapy between volumetric arc therapy and helical tomotherapy for unresectable malignant pleural mesothelioma. BioMed Res Int, 2019.

A4. Pehlivan B, Kucuk A, Mertsoylu H, Topkan E. Current management of brainstem gliomas. Int. J.Adv. Res. 7(9), 2019.

A5. Topkan E, Pehlivan B. Radiation-induced abscopal effects on cardiovascular system. IndJMedResPharmSci, 6(9), 2019.

A6. Golusinski P, Di Maio P, Pehlivan B, Colley S, Nankivell P, Kong A, Hartley A, Mehanna H. Evidence for the approach to the diagnostic evaluation of squamous cell carcinoma occult primary tumors of the head and neck. Oral Oncol. 2019 Jan;88:145-152.

A7. Topkan E, Selek U, Ozdemir Y, Besen AA, Guler OC, Yildirim BA, Mertsoylu H, Findikcioğlu A, Ozyılkan O, Pehlivan B. Risk factors for .fatal pulmonary hemorrahage following concurrent chemoradiotherapy in stage 3B/C squamous-cell lung carcinoma patients. J Oncol 2018 Nov 1;2018.

A8. Topkan E, Yildirim BA, Guler OC, Parlak C, Pehlivan B, Selek U.  Safety and palliative efficacy of single-dose-8-Gy reirradiation for painful local failure in patients with stage IV non-small cell lung cancer previously treated with radical chemoradiation therapy. Int J Radiat Oncol Biol Phys. 2015 Mar 15;91(4):774-80.

A9. Duman E, Cecen Y, Sındır B, Ozdemir B, Yıldırım M, Cecen S, Pehlivan B, Yavuz MN. Dosimetric evaluation of Adaptive Therapy in non-small lung cancer patients undergoing palliative thoracic Radiotherapy. Int J Hematol Oncol. 2015, 25:178-185.

A10. Mirimanoff RO, Ozsahin M, Thariat J, Ozyar E, Schick, Pehlivan B, Krengli M, Pellanda AF, Vess H. Cai L, Scandolaro L, Belacemi Y, Villa S, Igdem S, Lutsyk M, Miller RC. History of rare cancer network and past research. Rare Tumors. 2014 Aug 6;6(3):5462.

A11. Sarıca FB, Cekinmez M, Tufan K, Sen O, Onal HC, Mertsoylu H, Topkan E, Pehlivan B, Erdogan B, Altinors B. Five-year follow-up results for patients diagnosed with anaplastic astrocytoma and efeectiveness of concomitant therapy with temozolomide for recurrent anaplastic astrocytoma. Asian J Neurosurg. 2012 Oct;7(4):181-90.

A12. Topkan E. Parlak C, Topuk S, Pehlivan B. Influence on oral glutamine supplementation on survival outcomes of patients treated with concurrent chemoradiotherapy for locally advanced non-small cell lung cancer. BMC Cancer 2012 Oct 31;12:502. 

A13. Pehlivan B, Ares C, Lomax T, Stadelmann O, Goitein G, Timmermann B, Schneider RA, Hug EB.: Temporal lobe toxicity analyasis after proton radiation therapy for skull base tumors. Int J Radiat Oncol Biol Phys 2012 Aug 1;83(5):1432-40.

A14. Topkan E, Parlak C, Kotek A, Yuksel O, Cengiz M, Ozsahin M, Pehlivan B. Impact of prophylactic cranial irradiation timing on brain relapse rates in patients with stage IIIB non-small-cell lung carcinoma treated with two different chemoradiotherapy regimens. Int J Radiat Oncol Biol Phys 2012 July 15;83(4):1264-71.

A15. Pehlivan B, Onal C, Yavuz M.: Retinoblastoma Tedavisinde Eksternal Radyoterapinin Rolü ve Radyoterapi Seçenekleri. Int J. Hematol Oncol. 2012, 22(2):1-9.

A16. Topkan E, Parlak C, Kotek A, Yapar AF, Pehlivan B. Predictive value of metabolic    18FDG-PET response on outcomes in patients with locally advanced pancreatic carcinoma treated with definitive concurrent chemoradiotherapy. BMC Gastroenterol 2011 10,11:123. 

A17. Topkan E, Topuk S, Oymak E, Parlak C, Pehlivan B. Pseudoprogression in patients with glioblastoma multiforme after concurrent radiotherapy and temozolomide. Am J Clin Oncol 2012; 35(3):284-9. 

A18. Sarıca F, Tufan K, Çekinmez M, Şen O, Onal HC, Mertsoylu H, Pehlivan B, Erdoğan                       B, Altınors MN. Effectiveness of temozolomide treatment used at thesame time with radiotherapyand adjuvant temozolomid: concomitant therapy of glioblastoma multiforme:         multivariate analysis and other prognostic factors. J Neurosurg Sci. 2010; 54(1): 7-19.

A19. Ozsahin M, Gruber G, Olszyk O, Karakoyun-Celik O, Pehlivan B, Azria D, Roelandts M, Kaanders JH, Cengiz M, Krengli M, Matzinger O, Zouhair A.: Outcome and prognostıc factors ın olfactory neuroblastoma: a rare cancer network study. Int J Radiat Oncol Biol Phys. 2010 Nov 15;78(4):992-7.

A20. Yavuz MN, Topkan E, Yavuz AA, Aydin M, Onal C, Reyhan M, Kotek A, Pehlivan B, Yapar AF.: FDG-PET/CT Imaging-based taget volume delineation for preoperative conformal radiotherapy for rectal carcinoma. Int J Hematol Oncol 2010, 20(2):067-074.

A21. Pehlivan B, Topkan E, Onal C, Nursal GN, Yüksel O, Yavuz M, Yavuz A.: Comparison of CT and integrated PET-CT based radiation therapy planning in malign plevral mesothelioma patients. Radiat Oncol. 2009, 4:35. 

A22. Pehlivan B, Luthi F, Matzinger O, Betz M, Dragusanu D, Bulling S, Bron L, Pasche P, Seelentag W, Mirimanoff RO, Zouhair A, Ozsahin M.: Feasibility and efficacity of accelerated weekly concomitant boost postopeartive radiation therapy combined with concomitant chemotherapy in patients with locally advanced head and neck cancer. Ann Surg Oncol.  2009, 16:1337-1343.

A23. Pehlivan B, Pichenot C, Casting M, Auperin A, Arriagada R, Bourhis J.: Interfractional set-up errors evaluation by daily electronic portal imaging of IMRT in head and neck cancer patients. Acta Oncol. 2009, 48(3):440-5.

A24. Pehlivan B, Zouhair A, Luthi F, Bron L, Pasche P, Dragusanu D, Azria D, Matzinger O, Mirimanoff RO, Ozsahin M.: Decrease in hemoglobin levels following surgery influences the outcome in head and neck cancer patients treated with accelerated postoperative radiotherapy. Ann Surg Oncol.  2009, 16:1331-1336.

A25. Onal C, Arslan G, Topkan E, Pehlivan B, Yavuz M, Oymak E, Yavuz A.: Comparison of conventional and CT-based planning for intracavitary brachytherapy for cervical cancer: target volume coverage and organs at risk doses. J Exp Clin Cancer Res. 2009 Jul 1;28:95.

A26. Onal C, Pehlivan B, Bal N, Topkan E, Kilinc F, Topuk S. : Sarcomatoid Carcinoma of the Urinary Bladder Treated with Adjuvant Radiotherapy: A Case Report. Clinical Medicine: Case Reports 2009:2 39-42.

A27. Onal C, Yuksel O, Topkan E, Pehlivan B. : Bilateral glomus tumor treated with PET-CT based conformal radiotherapy: case report. Cases Journal 2009, 2:8402.

A28. Atahan IL, Yıldız F, Ozyar E, Pehlivan B, Genç M, Köse M, Tulunay G, Ayhan A, Yuce K, Güler N, Kucukali T.: Radiotherapy in the adjuvant setting of cervical carcinoma: treatment, results, and prognostic factors. Int J Gynecol Cancer 2007, 17 (4): 813-820.

A29. Garcia R, Bourhis J, Pehlivan B, Pichenot C, Alfonsi M.: Intensity modulated radiotherapy for cancers of the upper aerodigestive tract. Cancer Radiother 2007, 11(6-7):353-7.

  1. Pehlivan B, Zouhair A, Luthi F, Bron l, Pasche P, Seelentag W, Mirimanoff RO, Ozsahin M.: Accelerated weekly concomitant boost postoperative radiation therapy combined to concomitant chemotherapy in patients with locally advanced head and neck cancer. Scientific Association of Swiss Radiation Oncology (SASRO), 15-17.03.2007, Aarau, Switzerland.
  2. Pehlivan B, Ozsahin M, Bron L, Pasche P, HP Do, Luthi F, Mirimanoff RO, Pica A.: High-dose rate brachytherapy in the treatment of recurrent head and neck cancer. Scientific Association of Swiss Radiation Oncology (SASRO), 15-17.03.2007, Aarau, Switzerland.
  3. Pehlivan B, Ares C, Stadelmann O, Lomax T, Hug EB.: Clinical diagnosis of temporal lobe and brain necrosis following proton radiation therapy in chordoma and chondosarcoma patients. Internatinal Translational Research Congress in Radiation Oncology, 11-13.3.2009, Geneva, Switzerland.
  4. Ozsahin M, Olszyk O, Karakoyun-Celik O, Pehlivan B, Azria D, Roelandts M, Kaanders JH, Cengiz M, Krengli M, Zouhair A.: Outcome and prognostic factors in olfactory neuroblastoma: a multicenter rare cancer network study. American Society of Therapeutic Radiation Oncology (ASTRO), 16-20.10.2005, Denver, USA.
  5. Zouhair A, Dragusanu D, Matzinger O, Pehlivan B, Khanfir K, Ris HB, Stupp R, Moeckli RO, Ozsahin M.: Postoperative 3D conformal radiation therapy with dose-volume histogram assesment in non small-cell lung cancer. American Society of Therapeutic Radiation Oncology (ASTRO), 28.10-01.11.2007, Los Angeles, USA.
  6. Dhermain F, Ducreux D, Bidault F, Parker F, Pehlivan B, Beaudre A, Haie-Meder C, Bourhis J.: Radiotherapy planning for WHO grade 2 and grade 3 supra-tentorial gliomas: first experience with 10 consecutive patients. The European Cancer Conference (ECCO) 13, 30.10-3.11.2005, Paris, France.
  7. Atahan L, Yıldız F, Ozyar E, Pehlivan B, Köse F, Tulunay G, Ayhan A, Yüce K, Güler N, Küçükali T.: Radiotherapy in the adjuvant setting of cervical carcinoma: Treatments results and prognostic factors. European Society of Therapeutic Radiation Oncology (ESTRO) Annual Meeting: 8-12.10.2006, Leipzig, Germany.
  8. Pehlivan B, Pichenot C, Casting M, Auperin A, Arriagada R, Bourhis J.: Verification of patient position by daily electronic portal imaging in head and neck cancer traeted with IMRT. European Society of Therapeutic Radiation Oncology (ESTRO) Annual Meeting: 8-12.10.2006, Leipzig, Germany.
  9. Pehlivan B, Rutz HP, Goiten G, Haller K, Lomax A, Hug E, Timmermann B.: Case Report: Proton radiation therapy for secondary atypical lumbar meningioma arising 25 years after interdisciplinary treatment for advanced wilms tumor. European Society of Therapeutic Radiation Oncology (ESTRO) Annual Meeting: 14-18.9.2008, Göteborg, Sweden
  10. Yavuz M, Pehlivan B, Aydin M, Topkan E, Onal C, Reyhan M, Kotek A, Yapar AF, Yavuz AA.: Comparison of CT-guided and PET-CT guided radiotherapy planning in patients with rectum cancer treated preoperatively. The European Cancer Conference (ECCO) 15, 20- 24.09.2009, Berlin, Germany.
  11. Pehlivan B, Kotek A, Akkaneren S, Topkan E. Outcome of profilactic cranial irradiation in 112 patients with recursive partitioning analysis group I locally advanced (Stage IIIB) non-small cell lung carcinoma. European Society of Therapeutic Radiation Oncology (ESTRO) Annual Meeting: 12-16.9.2010, Barcelona, Spain.
  12. Pehlivan B, Yuksel O, Akkaneren Ş, Topkan E.Pseudoprogression in patients with glioblastome multiforme following concurrent radiotherapy and temozolomide. European Society of Therapeutic Radiation Oncology (ESTRO) Annual Meeting: 12-16.9.2010, Barcelona, Spain.
  13. Pehlivan B, Akkaneren Ş, Kotek A, Topkan E. Survival outcome in unresectable locally advanced pancreatic carcinoma patients treated with coregistered PET-CT based radiation therapy planning without elective nodal irradiation. European Society of Therapeutic Radiation Oncology (ESTRO) Annual Meeting: 12-16.9.2010, Barcelona, Spain.
  14. Pehlivan B, Oymak E, Kotek A, Akkaneren S, Topkan E. Oral glutamine supplementation for amelioration of acute radiation induced esophagitis has no negative impact on survival outcome in locally advanced non-small cell lung cancer treated with thoracic irradiation. European Society of Therapeutic Radiation Oncology (ESTRO) Annual Meeting: 12-16.9.2010, Barcelona, Spain.
  15. Pehlivan B, Zorlu F, Yıldız F, Gürkaynak M, Akyol F, Kars A, Atahan IL.: Preoperatif radyoterapi alan rektum kanserli hastalarda sonuçlarımız. Ulusal Kanser Kongresi, 21-25.4.2003, Antalya, Turkey.
  16. Pehlivan B, Zorlu F, Cengiz M, Akyol F, Gürkaynak M, Altundağ K, Tekuzman G, Atahan LI.: Opere mide kanserli hastalarda adjuvan radyoterapi sonuçları ve prognostik faktör analizi. Ulusal Radyasyon Onkolojisi Kongresi, 21-25 .4. 2003, Antalya, Turkey.
  17. Dhermain F, Pehlivan B, Ducreux D, Beaudre A, Bidault F, Parker F, Haie-Meder C, Lefkopoulos D, Bourhis J.: Grad 2 ve Grad 3 oligodendriogliomlu hastaların radyoterapi planlamasında fonksiyonel magnetik resonansın yeri:ilk 10 hastanın sonuçları. Ulusal Radyasyon Onkolojisi Kongresi. 19-23.4.2006, Antalya, Turkey.
  18. Yavuz MN, Pehlivan B, Aydın M, Topkan E, Önal C, Reyhan M, Kötek A, Yapar AF, Yavuz AA.: Rektum kanserinin preoperatif radyoterapisinde BT ile PET-BT bazlı 3-boyutlu konformal radyoterapi planlarının karşılaştırılması. XVIII. Ulusal Kanser Kongresi. 21-26 Nisan 2009, Antalya, Turkey.
  19. Pehlivan B, Yavuz M, Topuk S, Topkan E, Yavuz A.: Servikal vertebra agresif osteoblastomlu hastada 18- FDG-PET-BT bazlı küratif radyoterapi: olgu sunumu. Ulusal Kanser Kongresi, 21-26.4. 2009, Antalya,
  20. Sönmez A, Pehlivan B, Arslan G, Yavuz A, Topkan E, Sönmez S, Yavuz M.: Tüm vücut ışınlamasında multi leaf kolimatör ile ikincil alt alan tekniği. Ulusal Kanser Kongresi, 21-26.4.2009, Antalya, Turkey.
  21. Önal C, Oymak E, Arslan G, Pehlivan B, Topkan E, Yavuz MN, Yavuz AA.: İntrakaviter brakiterapi uygulanan serviks kanserli hastalarda konvansiyonel plan ile 3 boyutlu planın karşılaştırılması. XVIII. Ulusal Kanser Kongresi. 21-26 Nisan 2009, Antalya, Turkey.
  22. Önal C, Kayaselçuk F, Erdem R, Oymak E, Pehlivan B, Topkan E, Yavuz M, Bacanlı D, Yavuz A.: Radyasyon enteritinin önlenmesinde melatonin ve oktreotidin etkinliklerinin karşılaştırılması. XVIII. Ulusal Kanser Kongresi. 21-26 Nisan 2009, Antalya, Turkey.
  23. Pehlivan B, Topkan E, Acıbucu İ, Dölek Y, Önal C, Yavuz AA, Yavuz MN.: Meme Koruyucu Cerrahi veya Modifiye Radikal Mastektomi Sonrası 4 Farklı Teknikle 3 Boyutlu Konformal Radyoterapi Uygulanan Hastalardaki Karşı Meme Dozu. 30.09- 4.10. 2009, Çeşme, Turkey.
  24. Sönmez A, Pehlivan B, Önal C, Sönmez S, Arslan G, Yavuz AA.: Meme radyoterapisinde ‘field-in-field’ tekniği ile gerçekleşirilen şiddet modülasyonunun doz homojenitesine etkisi ve konvansiyonel wedgeli planlarla karşılaştırılması. Medikal Fizik Kongresi, 22-24.10.2009, Ankara, Turkey.
  25. Sönmez A, Arslan G, Sönmez S, Pehlivan B, Önal C, Yavuz MN.: Meme koruyucu cerrahi (MKC) sonrası 3 boyutlu konformal radyoterapi (3KRT) uygulanan hastalardaki setup hatalarının “field-in-field” (FIF)ve konvansiyonel wedge’li planlardaki doz dağılımına etkisinin karşılaştırılması. Medikal Fizik Kongresi, 22-24.10.2009, Ankara, Turkey.
  26. Sönmez A, Önal C, Pehlivan B, Sönmez S, Arslan G, Efe E, Yavuz AA.: Prostat radyoterapisinde 6-alan konformal radyoterapi ile 4-alan ‘field in field’ tekniklerinin karşılaştırılması. Medikal Fizik Kongresi, 22-24.10.2009, Ankara, Turkey.
  27. Sönmez A, Önal C, Sönmez S, Pehlivan B, Arslan G, Yavuz MN.: Mantle alan ışınlaması yapılan hastalarda ‘field-in-field’ tekniği ile dozun kompansasyonu. Medikal Fizik Kongresi, 22-24.10.2009, Ankara, Turkey.
  28. Pehlivan B, Ares C, Stadelmann O, Lomax A, Goitein G, Timmermann B, Schneider R, Hug EB. Protonterapi uygulanan kafa tabanı kordoma ve kondrosarkomalarında temporal lob toksisitesi analizi. Ulusal Radyasyon Onkolojisi Kongresi. 21-25.4.2010, Cyprus.
  29. Pehlivan B, Kötek A, Akkaneren Ş, Topkan E. PET-BT bazlı radyoterapi planlaması sonrası elektif nodal ışınlama yapılmaksızın tedavi edilen lokal ileri evre pankreas kanserinde sağkalım sonuçları. Ulusal Radyasyon Onkolojisi Kongresi. 21-25.4.2010, Cyprus.
  30. Pehlivan B. Kötek A, Akkaneren Ş, Topkan E. Lokal ileri evre küçük hücreli dışı akciğer kanseri tanısı nedeniyle ardışık veya eşzamanlı kemoradyoterapi uygulanan hastalarda profilaktik kranyal ışınlama. Ulusal Radyasyon Onkolojisi Kongresi. 21-25.4.2010, Cyprus.
  31. Pehlivan B, Yuksel O, Akkaneren Ş, Topkan E. Radyoterapi ve eş zamanlı temozolomid ile tedavi edilen glioblastoma multiforme hastalarında psödoprogresyon. Ulusal Radyasyon Onkolojisi Kongresi. 21-25.4.2010, Cyprus.
  32. Pehlivan B. Kötek A, Akkaneren Ş, Topkan E. Karaciğer metastazları tanılı hastalarda BT ve PET/BT füzyonu bazlı radyoterapi planlarının karşılaştırılması. Ulusal Radyasyon Onkolojisi Kongresi. 21-25.4.2010, Cyprus.
  33. Pehlivan B, Kötek A, Akkaneren Ş, Topkan E. FDG-PET/BT bazlı üç boyutlu konformal radyoterapi planı ile tedavi edilen karaciğer metastazlarında lokal kontrol ve sağkalım sonuçları. Ulusal Radyasyon Onkolojisi Kongresi. 21-25.4.2010, Cyprus.
  34. Pehlivan B, Kötek A, Akkaneren Ş, Topkan E. Profilaktik oral glutamin kullanımının eş zamanlı pelvik radyokemoterapiye bağlı akut diareyi önlemedeki etkisinin retrospektif olarak değerlendirilmesi. Ulusal Radyasyon Onkolojisi Kongresi. 21-25.4.2010, Cyprus.
  35. Pehlivan B, Oymak E, Akkaneren Ş, Kötek A, Topkan E. Profilaktik oral glutamine kullanımının torasik radyoterapi ile tedavi edilen küçük hücre dışı akciğer kanserlerinde radyoterapiye sağkalım üzerine etkisi. Ulusal Radyasyon Onkolojisi Kongresi. 21-25.4.2010, Cyprus.
  36. Pehlivan B, Yavuz MN, Bal N, Topkan C, Önal C, Yavuz AA. Radyoterapinin testiste oluşturduğu hasarın önlenmesinde amifostin, melatonin ve 5-androstenediol’unradyoprotektif etkinilklerinin karşılaştırılması. Ulusal Radyasyon Onkolojisi Kongresi. 21-25.4.2010,Cyprus.
  37. Kötek A, Pehlivan B, Acıbucu İ, Dölek Y, Yavuz AA, Yavuz E, Topkan E. Meme Koruyucu cerrahi veya modifiye radikal mastektomi sonrası 4 farklı teknikle 3 boyutlu konformal radyoterapi uygulanan hastalardaki karşı meme dozu. Ulusal Radyasyon Onkolojisi Kongresi. 21-25.4.2010, Cyprus.
  38. Eren Ş, Yüksel Ö, Kötek A, Oymak E, Topuk S, Pehlivan B, Önal C, Topkan E. “Servikal kanser tanılı ve brakiterapi uygulanamayan hastalarda üç boyutlu konformal boost tedavisi sonuçları. Ulusal Radyasyon Onkolojisi Kongresi. 21-25.4.2010, Cyprus.
Back to top button